Palvella Therapeutics Inc. (PVLA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Palvella Therapeutics Inc...

    NASDAQ: PVLA · Real-Time Price · USD
    60.00
    2.31 (4.00%)
    At close: Sep 26, 2025, 1:37 PM

    Palvella Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a 25.9M 31.42M
    Cost of Revenue
    		 n/a n/a 2.78M 2.37M
    Gross Profit
    		 n/a n/a 23.12M 29.05M
    Operating Income
    		 -14.1M -11.87M -43.47M -51.83M
    Interest Income
    		 n/a 6.26M 721K 4K
    Pretax Income
    		 -17.43M 18.69M -33.28M -45.74M
    Net Income
    		 -17.43M 18.69M -33.28M -45.74M
    Selling & General & Admin
    		 5.94M 3.08M 16.38M 16.68M
    Research & Development
    		 8.15M 8.79M 50.21M 64.2M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 14.1M 11.87M 66.6M 80.88M
    Interest Expense
    		 4.32M n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 14.1M 11.87M 69.38M 83.25M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 2.23M 1.27M 930.35K 806.84K
    Shares Outstanding (Diluted)
    		 2.23M 1.27M 930.35K 806.84K
    EPS (Basic)
    		 -7.83 14.74 -29.61 -56.69
    EPS (Diluted)
    		 -7.83 14.74 -29.61 -56.69
    EBITDA
    		 -13.12M 18.69M -30.5M -43.37M
    EBIT
    		 -13.12M 18.69M -33.28M -45.74M
    Depreciation & Amortization
    		 n/a n/a 2.78M 2.37M

    Add to Watchlist